A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia

Schizophrenia Research

Volumn 101, Issue 1-3, 2008, Pages 9-16

  Ohtsuki, Tsuyuka ^a,j   Koga, Minori ^a,j   Ishiguro, Hiroki ^a,j   Horiuchi, Yasue ^a,j   Arai, Makoto ^b   Niizato, Kazuhiro ^c   Itokawa, Masanari ^b   Inada, Toshiya ^d   Iwata, Nakao ^e   Iritani, Shyuji ^f   Ozaki, Norio ^f   Kunugi, Hiroshi ^g   Ujike, Hiroshi ^h   Watanabe, Yuichiro ⁱ   Someya, Toshiuki ⁱ   Arinami, Tadao ^a,j  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^d TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^j JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

more..

Author keywords

Expression; Glutamate; Luciferase; Prefrontal

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ASSAY; EXON; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOTROPIC GLUTAMATE RECEPTOR MGLUR7 GENE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 42749089847     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.01.027     Document Type: Article

References (25)

1. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
2. Bolonna A.A., Kerwin R.W., Munro J., Arranz M.J., and Makoff A.J. Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophr. Res. 47 1 (2001) 99-103
3. Boudin H., Doan A., Xia J., Shigemoto R., Huganir R.L., Worley P., and Craig A.M. Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site. Neuron 28 2 (2000) 485-497
4. Callaerts-Vegh Z., Beckers T., Ball S.M., Baeyens F., Callaerts P.F., Cryan J.F., Molnar E., and D'Hooge R. Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. J. Neurosci. 26 24 (2006) 6573-6582
5. Carlsson A., Hansson L.O., Waters N., and Carlsson M.L. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sci. 61 2 (1997) 75-94
6. Consortium WTC C. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447 7145 (2007) 661-678
7. Cryan J.F., Kelly P.H., Neijt H.C., Sansig G., Flor P.J., and van Der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci. 17 11 (2003) 2409-2417
8. Dev K.K., and Henley J.M. The schizophrenic faces of PICK1. Trends Pharmacol. Sci. 27 11 (2006) 574-579
9. Devlin B., and Roeder K. Genomic control for association studies. Biometrics 55 4 (1999) 997-1004
10. Flor P.J., Van Der Putten H., Ruegg D., Lukic S., Leonhardt T., Bence M., Sansig G., Knopfel T., and Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR 7b. Neuropharmacology 36 2 (1997) 153-159
11. Fujii K., Maeda K., Hikida T., Mustafa A.K., Balkissoon R., Xia J., Yamada T., Ozeki Y., Kawahara R., Okawa M., Huganir R.L., Ujike H., Snyder S.H., and Sawa A. Serine racemase binds to PICK1: potential relevance to schizophrenia. Mol. Psychiatry 11 2 (2006) 150-157
12. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 5576 (2002) 2225-2229
13. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 1 (2005) 40-68
14. Kinoshita A., Shigemoto R., Ohishi H., van der Putten H., and Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J. Comp. Neurol. 393 3 (1998) 332-352
15. Kosinski C.M., Risso Bradley S., Conn P.J., Levey A.I., Landwehrmeyer G.B., Penney Jr. J.B., Young A.B., and Standaert D.G. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J. Comp. Neurol. 415 2 (1999) 266-284
16. Makoff A., Pilling C., Harrington K., and Emson P. Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS. Brain Res. 40 1 (1996) 165-170
17. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., Stoehr N., Mombereau C., Kuhn R., McAllister K.H., van der Putten H., Cryan J.F., and Flor P.J. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 51 (2005) 18712-18717
18. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der Putten H., Flor P.J., and Cryan J.F. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 31 6 (2006) 1112-1122
19. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13 5 (1994) 1031-1037
20. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., and Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72 1 (2004) 29-39
21. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 1 (1995) 1-26
22. Reichenberg A., Weiser M., Caspi A., Knobler H.Y., Lubin G., Harvey P.D., Rabinowitz J., and Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J. Clin. Exp. Neuropsychol. 28 2 (2006) 193-207
23. Shigemoto R., Kulik A., Roberts J.D., Ohishi H., Nusser Z., Kaneko T., and Somogyi P. Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature 381 6582 (1996) 523-525
24. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., and Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 7 (2005) 631-636
25. Wilson G.M., Flibotte S., Chopra V., Melnyk B.L., Honer W.G., and Holt R.A. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum. Mol. Genet. 15 5 (2006) 743-749